What are you looking for?
Need help finding what you are looking for? Contact Us

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1454070

Cover Image

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1454070

Autoinjectors Market Forecasts to 2030 - Global Analysis By Type (Reusable, Disposable, Customized, Prefilled and Other Types), Therapy, Route of Administration, Technology, End User and By Geography

PAGES: 200+ Pages
DELIVERY TIME: 2-3 business days
PDF (Single User License)
USD 4150
PDF (2-5 User License)
USD 5250
PDF & Excel (Site License)
USD 6350
PDF & Excel (Global Site License)
USD 7500

Add to Cart

According to Stratistics MRC, the Global Autoinjectors Market is accounted for $111.1 billion in 2023 and is expected to reach $264.6 billion by 2030 growing at a CAGR of 13.2% during the forecast period. Autoinjectors are medical devices designed to deliver a single dose of a particular medication, typically in emergency situations such as severe allergic reactions (anaphylaxis) or other medical emergencies. They are compact, portable, and user-friendly devices that allow individuals to self-administer medication quickly and easily. These devices are commonly used for delivering medications such as epinephrine for allergic reactions, nerve agents' antidotes for military personnel, or medications for certain chronic conditions like multiple sclerosis or rheumatoid arthritis. They play a crucial role in emergency medical care, providing rapid delivery of life-saving medication when time is of the essence.

According to the National Health Interview Survey (NHIS), nearly 52% of the adult population in the US is diagnosed with at least one chronic condition, such as asthma, diabetes, and hypertension.

Market Dynamics:


Rising prevalence of chronic diseases

Conditions such as rheumatoid arthritis, multiple sclerosis, and diabetes are becoming more prevalent globally, driving the need for convenient and efficient drug delivery systems. Autoinjectors offer patients a user-friendly solution for self-administration of medications, contributing to their growing popularity in managing chronic conditions. This trend underscores the importance of innovation and accessibility within the healthcare sector to address the evolving needs of patients with chronic diseases.


Stringent regulatory requirements

Meeting stringent regulatory requirements poses significant challenges for companies operating in the market. These requirements encompass various aspects such as safety, efficacy, quality control, and manufacturing standards. Ensuring compliance with regulations set forth by regulatory bodies demands extensive testing, documentation, and adherence to strict guidelines throughout the product lifecycle. Non-compliance can lead to delays in product approval, costly recalls, and damage to the company's reputation.


Surge in anaphylaxis and severe allergic reactions

There has been a notable surge in anaphylaxis and severe allergic reactions within the autoinjectors market. This increase underscores the critical need for reliable and efficient delivery mechanisms for emergency treatment. Autoinjectors play a vital role in administering life-saving medication swiftly and accurately during such emergencies. As awareness grows and more individuals require access to these devices, the market is witnessing a heightened demand for improved technologies and innovations to address these urgent medical needs.


High cost of autoinjectors

The high cost of autoinjectors remains a significant challenge in the market. These devices, crucial for delivering medications such as epinephrine for severe allergic reactions, are often priced prohibitively high, posing financial burdens for patients and healthcare systems. Despite their lifesaving potential, the inflated prices limit accessibility, leading to concerns about equitable healthcare access. Efforts to address this issue include advocating for generic alternatives and increasing transparency in pricing to mitigate the financial strain on patients.

Covid-19 Impact:

The COVID-19 pandemic has significantly impacted the autoinjectors market. Initially, disruptions in the supply chain led to shortages and delays in manufacturing and distribution. However, as the pandemic progressed, there was a surge in demand for autoinjectors due to increased focus on self-administration of medications and the need for remote healthcare. This led to a growing market for autoinjectors, driven by factors such as the rise in chronic diseases and the preference for home healthcare solutions amidst the pandemic's challenges.

The disposable segment is expected to be the largest during the forecast period

The disposable segment is expected to be the largest during the forecast period. These devices offer ease of use and reduced risk of needlestick injuries, enhancing patient compliance and safety. Factors such as increasing prevalence of chronic diseases and expanding applications of biologics drive market expansion. Additionally, advancements in technology and product innovations contribute to market growth.

The diabetes segment is expected to have the highest CAGR during the forecast period

The diabetes segment is expected to have the highest CAGR during the forecast period driven by rising prevalence of diabetes globally and advancements in self-administration technologies. Autoinjectors offer convenience and accuracy in insulin delivery, enhancing patient compliance. Moreover, increasing investments in research and development aimed at improving device efficacy and patient experience are expected to sustain market momentum, fostering innovation and competition among key industry players.

Region with largest share:

North America is projected to hold the largest market share during the forecast period attributed to the rising prevalence of chronic diseases like diabetes and rheumatoid arthritis. Additionally, the increasing adoption of self-administration devices and technological advancements in drug delivery systems are driving market expansion. Furthermore, favorable government initiatives and reimbursement policies support the widespread adoption of autoinjectors across the region, fostering market development.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The prevalence of chronic diseases such as diabetes, rheumatoid arthritis, multiple sclerosis, and anaphylaxis is increasing in the region. Regulatory bodies in various countries across the Asia Pacific region are increasingly focusing on ensuring the safety and efficacy of medical devices, including autoinjectors. The aging population in countries is driving the demand for autoinjectors as elderly individuals often require regular medication for chronic conditions.

Key players in the market

Some of the key players in Autoinjectors market include Pfizer, Inc, Eli Lilly and Company, AbbVie Inc, GlaxoSmithKline plc, Mylan N.V., Johnson & Johnson, Sanofi, Amgen Inc, Merck KGaA, Antares Pharma, Inc., Becton, Dickinson, and Company, Janssen Global Services, LLC, Teva Pharmaceutical, Novartis AG, Bayer AG, SHL Medical, Solteam Medical, Stevanato Group and Boehringer Ingelheim International GmbH.

Key Developments:

In May 2023, Boehringer Ingelheim International GmbH announced that the U.S. FDA has approved the Cyltezo Pen, an autoinjector option for Cyltezo (adalimumab), an FDA-approved interchangeable biosimilar to Humira.

In May 2023, SHL Medical and MoonLake Immunotherapeutics collaborated to develop the sonelokimab autoinjector. SHL Medical's Molly autoinjector technology will be utilized for the clinical and potential commercial supply of MoonLake's Nanobody sonelokimab.

Types Covered:

  • Reusable
  • Disposable
  • Customized
  • Prefilled
  • Other Types

Therapies Covered:

  • Oncology
  • Asthma
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Anaphylaxis
  • Hormone therapy
  • Diabetes
  • Migraine
  • Other Therapies

Route of Administrations Covered:

  • Intramuscular
  • Subcutaneous

Technologies Covered:

  • Manual
  • Spring-Loaded
  • Battery-Powered
  • Other Technologies

End Users Covered:

  • Hospital & clinics
  • Homecare settings
  • Ambulatory Care Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Product Code: SMRC25622

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Autoinjectors Market, By Type

  • 5.1 Introduction
  • 5.2 Reusable
  • 5.3 Disposable
  • 5.4 Customized
  • 5.5 Prefilled
  • 5.6 Other Types

6 Global Autoinjectors Market, By Therapy

  • 6.1 Introduction
  • 6.2 Oncology
  • 6.3 Asthma
  • 6.4 Rheumatoid arthritis
  • 6.5 Multiple sclerosis
  • 6.6 Anaphylaxis
  • 6.7 Hormone therapy
  • 6.8 Diabetes
  • 6.9 Migraine
  • 6.10 Other Therapies

7 Global Autoinjectors Market, By Route of Administration

  • 7.1 Introduction
  • 7.2 Intramuscular
  • 7.3 Subcutaneous

8 Global Autoinjectors Market, By Technology

  • 8.1 Introduction
  • 8.2 Manual
  • 8.3 Spring-Loaded
  • 8.4 Battery-Powered
  • 8.5 Other Technologies

9 Global Autoinjectors Market, By End User

  • 9.1 Introduction
  • 9.2 Hospital & clinics
  • 9.3 Homecare settings
  • 9.4 Ambulatory Care Settings
  • 9.5 Other End Users

10 Global Autoinjectors Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Pfizer, Inc
  • 12.2 Eli Lilly and Company
  • 12.3 AbbVie Inc
  • 12.4 GlaxoSmithKline plc
  • 12.5 Mylan N.V.
  • 12.6 Johnson & Johnson
  • 12.7 Sanofi
  • 12.8 Amgen Inc
  • 12.9 Merck KGaA
  • 12.10 Antares Pharma, Inc.
  • 12.11 Becton, Dickinson, and Company
  • 12.12 Janssen Global Services, LLC
  • 12.13 Teva Pharmaceutical
  • 12.14 Novartis AG
  • 12.15 Bayer AG
  • 12.16 SHL Medical
  • 12.17 Solteam Medical
  • 12.18 Stevanato Group
  • 12.19 Boehringer Ingelheim International GmbH
Product Code: SMRC25622

List of Tables

  • Table 1 Global Autoinjectors Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Autoinjectors Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Autoinjectors Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 4 Global Autoinjectors Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 5 Global Autoinjectors Market Outlook, By Customized (2021-2030) ($MN)
  • Table 6 Global Autoinjectors Market Outlook, By Prefilled (2021-2030) ($MN)
  • Table 7 Global Autoinjectors Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 8 Global Autoinjectors Market Outlook, By Therapy (2021-2030) ($MN)
  • Table 9 Global Autoinjectors Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 10 Global Autoinjectors Market Outlook, By Asthma (2021-2030) ($MN)
  • Table 11 Global Autoinjectors Market Outlook, By Rheumatoid arthritis (2021-2030) ($MN)
  • Table 12 Global Autoinjectors Market Outlook, By Multiple sclerosis (2021-2030) ($MN)
  • Table 13 Global Autoinjectors Market Outlook, By Anaphylaxis (2021-2030) ($MN)
  • Table 14 Global Autoinjectors Market Outlook, By Hormone therapy (2021-2030) ($MN)
  • Table 15 Global Autoinjectors Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 16 Global Autoinjectors Market Outlook, By Migraine (2021-2030) ($MN)
  • Table 17 Global Autoinjectors Market Outlook, By Other Therapies (2021-2030) ($MN)
  • Table 18 Global Autoinjectors Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 19 Global Autoinjectors Market Outlook, By Intramuscular (2021-2030) ($MN)
  • Table 20 Global Autoinjectors Market Outlook, By Subcutaneous (2021-2030) ($MN)
  • Table 21 Global Autoinjectors Market Outlook, By Technology (2021-2030) ($MN)
  • Table 22 Global Autoinjectors Market Outlook, By Manual (2021-2030) ($MN)
  • Table 23 Global Autoinjectors Market Outlook, By Spring-Loaded (2021-2030) ($MN)
  • Table 24 Global Autoinjectors Market Outlook, By Battery-Powered (2021-2030) ($MN)
  • Table 25 Global Autoinjectors Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 26 Global Autoinjectors Market Outlook, By End User (2021-2030) ($MN)
  • Table 27 Global Autoinjectors Market Outlook, By Hospital & clinics (2021-2030) ($MN)
  • Table 28 Global Autoinjectors Market Outlook, By Homecare settings (2021-2030) ($MN)
  • Table 29 Global Autoinjectors Market Outlook, By Ambulatory Care Settings (2021-2030) ($MN)
  • Table 30 Global Autoinjectors Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Have a question?

Jeroen Van Heghe

Manager - EMEA



Christine Sirois

Manager - Americas


Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!